Study of SPARC1103 in Subjects With Spasticity
Completed · Phase 2 · Has a placebo group
Conditions studied: Spasticity
In brief
Study of SPARC1103 in subjects with spasticity
Key facts
- Study ID
- NCT02027025
- Run by
- Sun Pharma Advanced Research Company Limited
- People needed
- 142
- Starts
- 2014-04-21
- Expected to finish
- 2017-04-28
- Last updated by the study team
- 2019-05-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women greater than or equal to 18 years of age
- Willing to sign the informed consent form
- Women of child bearing potential willing to practice an acceptable method of birth control
- Known history of spasticity due to MS
You may not qualify if…
- Administration of an investigational drug or device within 30 days prior to Screening Visit 1
- Unable to comply with trial procedures in the opinion of the Investigator
- Concomitant neurologic conditions causing spasticity
- Any medical condition, including psychiatric disease or epilepsy, which would interfere with the interpretation of the trial results
Where it is running
- SPARC Site 4 — Long Beach, California, United States
- SPARC Site 6 — San Diego, California, United States
- SPARC Site 10 — Aurora, Colorado, United States
- SPARC Site 2 — Jacksonville, Florida, United States
- SPARC Site 15 — Miami, Florida, United States
- SPARC Site 7 — Miami Springs, Florida, United States
- SPARC Site 5 — Orlando, Florida, United States
- SPARC Site 13 — Tampa, Florida, United States
- SPARC Site 11 — Kansas City, Kansas, United States
- SPARC Site 3 — Lenexa, Kansas, United States
- SPARC Site 1 — Bingham Farms, Michigan, United States
- SPARC Site 14 — Albuquerque, New Mexico, United States
- SPARC Site 9 — Charlotte, North Carolina, United States
- SPARC Site 8 — Cleveland, Ohio, United States
- SPARC Site 12 — Richland, Washington, United States
- SPARC Site 18 — Moscow, Russia
- SPARC Site 17 — Nizhny Novgorod, Russia
- SPARC Site 20 — Samara, Russia
- SPARC Site 19 — Smolensk, Russia
- SPARC Site 16 — Ufa, Russia
- SPARC Site 22 — Dnipro, Ukraine
- SPARC Site 21 — Ivano-Frankivsk, Ukraine
- SPARC Site 23 — Lviv, Ukraine
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.